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Abstract 
Background. Neurodevelopmental follow-up in Neonatal Hypoxic Ischaemic 
Encephalopathy (HIE) typically focusses on major neuromotor (cerebral palsy, CP) and 
severe cognitive impairment. Outcomes in those without major neuromotor impairment are 
less well explored. 
Objectives. To examine behavioural, cognitive and neurological outcomes after neonatal 
HIE, in a clinical cohort of children without CP, at age 2 years. 
Methods. Clinical routine outcome data from children admitted to a tertiary centre with 
neonatal HIE for hypothermia treatment between 05/08/09 - 30/05/2016. Children were 
assessed for neuromotor status – particularly minor neurological signs (MNS), with Bayley 
Scales of Infant and Toddler Development III (Bayley III) or Ages and Stages Questionnaire- 
3 (ASQ), Child Behavior Checklist 1.5-5 (CBCL), Quantitative Checklist for Autism in 
Toddlers (Q-CHAT). 
Results Of 107 children, 75.5% had normal neurology, 12.1% CP, 12.1% MNS. Children 
with CP were excluded from analyses. For those without CP, Bayley-III scores were in the 
average range for the majority; mild cognitive delay observed in 5%, 4.2% language, 1.3% 
motor development; severe delay in 1.3% for cognitive, 4.2% for language. More than in the 
normative population scored in clinical ranges for CBCL externalising, sleep, and other 
problems. No significant difference was seen for Q-CHAT. Children with MNS were 
significantly more likely to have impaired Bayley-III scores, parent-reported internalising, 
sleep, and other problems. 
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Conclusions. In this clinical cohort, the majority of children had favourable outcome at 2 
years. However, children with MNS were at risk for cognitive and behavioural difficulties 
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Neonatal Hypoxic Ischaemic Encephalopathy (HIE) as a consequence of peripartum asphyxia 
is a major cause of neurological injury, affecting 1.3-1.7 newborns per 1000 live births in 
middle to high income countries 1. Children surviving neonatal HIE are at increased risk of 
adverse outcomes including severe neuromotor impairment (cerebral palsy, CP), global 
cognitive impairment, visual and/or hearing impairment, and epilepsy. 
Therapeutic hypothermia (TH) has now become standard care for infants with moderate or 
severe HIE. Several large randomized controlled trials 2–4 have shown that TH reduces both 
mortality and severe neurodisability. These effects appear to continue to school age 3–5, 
although there are some inconsistent results between studies with regards to 
neurodevelopmental outcomes. 
The British Association of Perinatal Medicine and The National Institute for Health and Care 
Excellence (NICE) currently recommend that a formal neurodevelopmental assessment is 
carried out at around 2 years of age in children surviving neonatal HIE. These assessments 
typically comprise a developmental assessment such as the Bayley Scales of Infant and 
Toddler Development, but information about behavioural impairments or social and 
emotional functioning is rarely reported. After this, the children are typically discharged from 
clinical follow-up unless they have global developmental or severe neuromotor impairment 
(CP). 
Studies examining long term outcomes have typically focused on outcomes of HIE such as 
CP and global cognitive impairment There is little information 6,7 on whether there are 
specific groups of children surviving HIE without major neuromotor impairment that may be 
at heightened risk of cognitive and/or behavioural impairment, and the majority of 
information dates from the period prior to TH becoming routine clinical practice. However, 
some studies have shown that even in the absence of such global impairments 8–10 children 
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with HIE may also exhibit motor, cognitive and behavioural impairments 11,12, and a recent 
systematic review 13 indicates that in the absence of CP, a high proportion of survivors of 
HIE remain at risk of general and/or specific cognitive impairments, even after TH. Current 
evidence for behavioural problems is limited 13 . 
 
Thus, this indicates that it is important to assess cognitive and behavioural outcomes of 
children with HIE with and without CP separately. In the present study, which investigates a 
clinical single centre cohort, we therefore focus on those children who have survived without 
developing severe neuromotor impairment. The aim of the current study is to describe the 
neurological, cognitive, and behavioural outcomes at a developmental age 2 years of a 
clinical sample of children who were admitted to a Neonatal Intensive Care Unit (NICU) for 





Secondary analysis of anonymised routinely collected clinical data data on this sample of 
children was approved by the University of Southampton Research Ethics Committee (Ethics 
ID: 26356) and the HRA and Health and Care Research Wales, HCRW (Reference ID 
20/HRA/0260; IRAS project ID 278072; University Hospital Southampton R&D protocol 
number RHM CHI1047). 
 
 
2.1. Study Population 
 
Infants were enrolled in the study if they had been admitted to the neonatal unit at University 
Hospital Southampton between 05/08/09 to 30/05/2016 for consideration of hypothermia 
treatment and enrolled in the clinical follow-up programme. Exclusion criteria were causes 
for encephalopathy other than perinatal asphyxia, genetic or syndromal disorders and not 
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receiving the full 72 hours of TH. Our criteria for TH are: gestational age 36 weeks 
(however, in this clinical cohort, there were 3 infants who were born <36 weeks, 1 at 34 
weeks, and 2 at 35 weeks of gestation, who received TH) and at least one of the following: 
Apgar score of 5 or less 10 min after birth; continued need for resuscitation, including 
endotracheal or mask ventilation, 10 min after birth; or acidosis (defined as pH <7 or base 
deficit >15 mmol/L, or both, in umbilical cord blood or any blood sample) within 1 h of birth 
14, and showed signs of moderate to severe encephalopathy. Severity of encephalopathy was 
classified using the modified Sarnat and Sarnat 15 staging; altered state of consciousness 
(reduced or absent response to stimulation), abnormal tone, and abnormal primitive reflexes 
(weak or absent suck or Moro response). In line with clinical protocol of this centre which is 
set to avoid delay in initiation of TH, amplitude integrated EEG (aEEG) was not used to 
determine initiation of TH. 
 
 
2.2. Neurodevelopmental Assessment 
 
Children were assessed in the follow-up clinic using a standardised protocol carried out by a 
Paediatric Neurologist or Neonatologist with experience in neurological and developmental 
assessments, together with a Physiotherapist. 
2.2.1. Structured neurological examination 
 
Neurological examination included assessment of cranial nerve function, movements, 
posture, reflexes, and muscle tone. Neurological status was categorised as normal 
(completely normal neurologic status), minor neurological signs (gross or fine motor 
coordination difficulties, muscle tone imbalance, without definite signs of cerebral palsy 
[CP]), or abnormal (signs of CP present as defined by the Surveillance of Cerebral Palsy in 
Europe Working Group, SCPE, 2000 16). Assessors were not blind to the neonatal course 




2.2.2. Developmental Assessment 
 
2.2.2.1. Bayley Scales of Infant and Toddler Development –III 
 
The Bayley Scales of Infant and Toddler Development –III (Bayley-III) 17 is a standardised 
assessment which consists of a series of developmental play tasks. Composite scores are 
derived for cognitive, language, and motor development and scaled to a metric, with a mean 
of 100, standard deviation of 15, and range of 40 to 160. Mild impairment was defined as a 
composite score ≥1 – 1.5 SD below the mean, and severe impairment as a composite score ≥2 
SD below the mean. 
 
 
2.2.2.2. Ages and Stages Questionnaire-3 (ASQ) 
 
Where the Bayley-III could not be completed due to non-compliance, parents completed the 
Ages and Stages Questionnaire-3 (ASQ) instead. The ASQ is a questionnaire that screens 
children for development in the areas of communication, gross and fine motor development, 
personal-social development, and problem-solving skills. It can be used for children aged 
between one month and 5½ years. The ASQ has been found to have similar predictive value 
for follow-up decisions to the Bayley-III 18. 
 
2.2.3. Behaviour including attention and autism spectrum disorder symptoms 
 
2.2.3.1. Child Behavior Checklist 1.5 -5 (CBCL) 
 
The parental version of the Child Behavior Checklist 1.5-5 (CBCL) was used to screen for 
behavioural difficulties. The CBCL 1.5-5 uses parental and/or teacher behavioural ratings to 
detect emotional and behavioural problems in preschool-aged children. It provides normed 
scales of Internalising, Externalising, and Total Problems derived from subscales including 
emotionally reactive, anxious/depressed, withdrawn behaviour, somatic complaints, for the 
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internalising scale; attention problems and aggressive behaviour for the externalising scale; 
sleep and other problems 19. As recommended by Achenbach & Edlebrock (1993) 20, we used 
raw scores in the analysis as they are more precise and uniform than t-scores. The normative 
sample of the CBCL is based on data from parental report of 700 healthy children from 40 
different states in the United States. 
 
 
2.2.3.2. Quantitative Checklist for Autism in Toddlers (Q-CHAT) 
 
The Q-CHAT is a 25-item parental report of autistic behaviour which assesses domains of 
joint attention, pretend play, language development, repetitive behaviours, and other aspects 
of social communication. The psychometric properties and predictive value of Q-CHAT have 
been previously examined 21 and the tool has a range of scores which approximate normal 
distribution 22. The Q-CHAT is able to discriminate between toddlers with and without a 
diagnosis of autism, however, to date, a cut-off point above which children would be invited 
for further assessment is yet to be validated. To evaluate the Q-CHAT scores in the present 
study, the mean +2SD for the normative population reported in Allison and colleagues’ paper 
(mean for normative population 26.7, SD 7.8; boys 27.5, SD 7.8; girls 25.8, SD 7.8) were 




Outcomes are first reported across the whole sample of tested children, then comparisons are 
made between children with minor neurological signs (MNS) and normal neurology. 
Children with a diagnosis of Cerebral Palsy are excluded from these comparison analyses. 
Statistical tests were conducted using IBM SPSS Statistics 25. Differences between groups 
were assessed with independent samples t-test where data were normally distributed and 
continuous and Mann-Whitney U test where the data were non-normally distributed and 
9 
 
continuous, and with Fisher’s Exact tests for categorical data (as some cells contained fewer 
than 5 samples). Comparisons between group means and published norms were made using a 
one sample t-test. Where categories were determined from continuous data e.g. mild or severe 
delay on assessment with the Bayley Scales, or borderline or clinical range in CBCL, 





As shown in Figure 1, 194 newborns were admitted for TH between 05/08/09 to 30/05/2016. 
Seventeen were excluded from the present analysis as they had a primary diagnosis other than 
HIE due to perinatal asphyxia; 17 (8.8%) infants were excluded since they did not receive TH 
or TH was not administered for the full 72 hours since the treating clinician either felt after 
review that TH was not indicated at all, or could be stopped before 72 hours of treatment. Of 
the 140 infants who had a primary diagnosis of perinatal asphyxia as a cause for 
encephalopathy and who received 72 hours of TH, 13 (9.3%) died. Of the 127 surviving 
newborns, 20 (15.7%) were lost to follow up, 107 (84.3 % of the survivors) received follow- 
up at age 2 years. Of those, 87 (81.3%) were assessed according to our standardised 
neurodevelopmental follow-up protocol (see below), and information on neurological 
outcome was available for further 20 (18.7%) children who were seen by their Neonatologist 
or Paediatrician for follow-up but were not formally assessed by the Paediatric Neurologist or 
according to the standardised protocol. The mean age of the tested children was 25.9 months 
(SD 2.6 months; min 21 - max 32.1 months). The baseline characteristics of the surviving 
infants for whom follow-up data were available did not differ significantly from those who 
were lost to follow-up (Table 1). 
 
 
3.1. Neuromotor outcomes 
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Of the 107 children with information on neuromotor outcome, 81 (75.7%) had normal 
neurology, 13 (12.1 %) had minor neurological signs, and 13 (12.1 %) had CP. The children 
with a diagnosis of CP were excluded from subsequent analyses, leaving a final sample for 
analysis of 94 children. 
 
 
3.2. Developmental outcomes 
 
Analyses of developmental outcomes were performed on the sample of children who had not 
developed CP by the age of 2 years (n=94). 71 of the 94 children (75.5 %) were assessed with 
the Bayley-3 Scales and in 10 (10.6%) developmental screening was performed with the 




3.2.1. Bayley-III Scales 
 
For children (without CP) tested with the Bayley-III Scales (n=71), mean Bayley composite 
scores were broadly average, see Table 2. When considering the presence of delay, 94.4% of 
tested children had normal cognitive scores (>85), 4.2% mild cognitive delay (70-85), and 
1.4% severe cognitive delay (<70); 92.2% had normal language scores (>85), 3.1% mild 
language delay (70-85) and 4.7% severe language delay (<70); and 98.5% had normal motor 
scores (>85), 1.5% mild motor delay (70-85), none had severe motor delay (<70). 
 
 
3.2.2. Ages and Stages Questionnaire-3 
 
Ten children had developmental screening with the ASQ. The majority of children in this 
subgroup had scores in the normal range for all areas that were assessed (for communication 
10/10; gross motor development 8/10; fine motor development 9/10, problem solving skills 
development 9/10, and personal-social development 9/10). Eight of the 10 children had 
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normal neurology, and 2/10 had MNS. Visual inspection of the date indicated that there was 
no obvious difference between those with normal neurology and those with MNS (see Table 
3). However, it has to be kept in mind that the sample size was very small. 
 
 
3.2.3. Assessment of behaviour 
 
3.2.3.1. Screening for autism spectrum symptoms with the QCHAT 
 
Information from the QChat was available for 71 (75.5%) of the 94 children without CP. The 
mean score across all tested children was 28.0 (SD 9.4; min 12-max 56). This was not 
significantly different from the published norm of 26.7 (Allison et al., 2008); one sample t- 
test, t (0.97), mean difference = 1.05, p = 0.33). There was weak evidence (p=0.07) for those 
with MNS (n=10; mean score 32.7, SD 10.4) showing more autistic spectrum disorder 
symptoms than those with normal neurology (n=61; mean score 26.9, SD 8.6). 
 
 
3.2.3.2. Screening for internalising, externalising, sleep and other problems with the CBCL 
Information from the CBCL was available for 74 (78.7 %) of the 94 children without CP. 
Table 4 shows the mean scores for total problem scale, internalising and externalising 
problems, sleep problems, and other problems. On the CBCL, 72.9% of children had total 
problem scores in the normal range, 10.8% in the borderline range, and 17.6 % in the clinical 
range. For internalising problems, 85.1 % scored in the normal range, 5.4% were in the 
borderline clinical range and 9.5% in the clinical range. For externalising problems, 74.3% of 
children scored in the normal range, 6.8% in the borderline clinical range, and 18.9% in the 
clinical range. Clinically relevant sleep problems were reported for 8.4% of the children, 
borderline scores for 7.3%, and 84.3% had scores in the normal range for sleep behaviour. 
In comparison, normative published means show that, for total problems, externalising and 
internalising scores, 82% of children scored in the normal range, 8% in the borderline range, 
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and 10% in the clinical range. For sleep problems, normative means report that 92% of 
children score in the normal range, 5% in the bordeline range and 3% in the clinical range 20. 
 
Comparing the group with MNS (n = 10) with those with normal neurology (n = 64), total 
problem scores were significantly (p = 0.04; Table 4) higher in the group with MNS. Looking 
at the component parts of the overall score, there was a significant difference between groups 
for reported sleep problems (p = 0.04), “other problems” (p = 0.01) and internalising 
problems (p = 0.03). There was no difference between those with MNS and normal 
neurology for externalising problems (p = 0.09). The observed differences between the two 
groups on the internalising scale were most pronounced for the subscales screening for 
anxious/depressed behaviour (p=0.04), somatic complaints (p = 0.07), emotionally reactive 
behaviour (p = 0.06). For the externalising scale, there was weak evidence that aggressive 





When the whole sample of 2 year old children with HIE who survived without developing CP 
are considered, the majority of children scored in the normal range on cognitive, motor and 
language assessments. CBCL total scores in children with HIE prior to TH becoming 
standard clinical care report similar overall rates of total problems to those observed in our 
study, but the breakdown of total problems score into the subcomponents was not reported 23. 
Our data add to the literature on the particular types of behavioural problems that children 
with HIE treated with TH might experience. In our sample, the proportion of children 
experiencing internalising problems was similar to that observed in the general population 
(when compared to test norms); our data suggest that high rates of overall problems on the 
CBCL total problems score are specific to difficulties with externalising problems and sleep. 
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The pattern of findings for performance on the Bayley Scales were similar, with composite 
scores similar to those reported in the general population. It is tempting to speculate that TH 
may not be protective with regards to more subtle behavioural problems. However, current 
evidence is limited, and more research is required here. 
 
 
In our cohort, 75.7% of children were neurologically normal, 12.1% had CP (and were 
excluded from our analyses) and 12.1% had minor neurological signs. The rate of CP is lower 
than that reported for toddler age from the large RCTs on therapeutic hypothermia 24 but 
similar rates have been reported from observational studies 25. Comparison of the rate of 
MNS is difficult, since this has not been previously reported in children with HIE treated with 
TH at toddler age. This, however, appears to be an important group since they were found to 
consistently experience more difficulties across multiple domains than the children with HIE 
and normal neurology. Children with MNS differed from children with normal neurology in 
multiple domains, with significantly lower cognitive, language and motor scores, as well as 
slightlyhigher ratings of autistic traits (Q-CHAT). Children with MNS scored higher on the 
total problem and internalising scales and had higher scores for parent reported sleep 
problems on the CBCL than children with normal neurology. Analysis of the individual 
subscales of the CBCL showed that children with MNS had higher scores in the domain of 
anxiety/depression, and this difference was approaching significance for emotionally reactive 
and somatic complaints subscales . 
 
 
In the context of those children with MNS having lower cognitive scores, and screening for 
behavioural and sleep problems indicating more difficulties than for those with normal 
neurological examination, the concept of Minor Neurological Dysfunction (MND) is of 
interest. Minor neurological dysfunction, usually not diagnosed before school age, describes a 
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neurological profile that includes difficulties with muscle tone regulation, posture, balance, 
coordination, mildly abnormal reflexes and cranial nerve function 26. Whilst the complex 
form of MND has been linked to learning, cognitive and motor problems in school aged 
children born very or extremely preterm 27,28, both the presence of MNS or MND, and 
whether it is linked to other aspects of cognitive and behavioural development, has not been 
previously reported in children with HIE. It has to be noted that the presence of MNS at 
toddler age does not necessarily mean that these children will go on to have MND later in 
life. The children in our cohort are too young for a formal assessment of MND with the 
currently available tools (i.e. Touwen Neurological Examination) and therefore it is not 
possible to assign a diagnosis of MND to the children in our cohort in whom MNS were seen. 
Currently, there is work going on for validation of an assessment for MND that can be used at 
toddler age (Hempel Assessment) to identify MND, but validity and reliability data are not 
yet available for the populations of infants with HIE or born preterm. However, it seems 
reasonable to infer from our findings of associations between MNS and poorer performance 
on cognitive assessment and behavioural difficulties’ screening that those with MNS need 
enhanced surveillance and specific assessment for MND once they reach school age. 
 
 
Comparison with other studies is difficult since, to our knowledge, no data on MNS at toddler 
age in the context of HIE have been reported. Some information is available for school age. 
Marlow et al (2005) 29, in a regional cohort of school aged children with neonatal 
 
encephalopathy (not treated with TH), using the Touwen assessment for MND, did not find 
an increased prevalence/incidence of MND in the absence of CP. However, this is the only 
study looking at MND in children with neonatal HIE and more research is needed to either 
replicate or disconfirm this, in particular for children who were born in the era of TH. 
Furthermore, at older ages, outcome assessments vary for the few existing studies, with most 
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studies focussing on assessment of motor function and not including assessment of minor 
neurological signs similar to that used in our study. However, comparison is possible with 
regards to occurrence of atypical neuromotor signs generally. Perez et al, 2013 6, described 
for a cohort of school and teenage age children with a history of neonatal HIE (not treated 
with TH) who had survived without developing CP, impairment in motor speed and quality 
of movements, and this was related to impairment of general cognitive abilities. This is in 
line with our findings. No data on behavioural outcomes were, however, reported for this 
cohort. More recently, two papers were published on one small sample size cohort of 6-8 year 
of children who underwent TH. These studies reported that the total score on the Movement 
Assessment Battery for Children-2 (M-ABC) was significantly lower (indicating poorer 
motor performance) in children with HIE compared to controls 11,12 , and associations 
between MABC-2 with Full Scale IQ, working memory and perceptual reasoning scores, 
with those showing poorer performance on motor tests performing poorer on the cognitive 
tests. One of the papers noted poor predictive value of Bayley-3 motor composite score at 18 
months on MABC-2 scores at age 6-8 years, again indicating that long term follow up is 
essential 11. 
 
Children with developmental difficulties can experience a widening gap on starting school, 
when cognitive and behavioural demands increase, and specific learning difficulties are more 
readily observed, as documented in the literature on school readiness 30,31. Thus, it is 
important to assess the longer term developmental trajectory of children with HIE. A recent 
systematic review of the literature that focused on follow-up studies in cohorts aged 4 years 
or older reported that a large proportion of children with HIE without CP are at increased risk 
of cognitive impairment, with specific cognitive difficulties in attention, language and 
executive functions, and limited evidence for behavioural problems 13. A wider range of more 
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focussed developmental assessments exist to assess school aged children and the presence of 




Comparison with another group of infants with early brain injury or atypical brain 
development, i.e. children born very or extremely preterm, shows a similar pattern of 
associations between neuromotor signs in the absence of CP and cognitive and/or behavioural 
function as in our cohort 27,28. This might suggest that, despite injury to the brain occurring at 
different developmental stages in these two groups, subsequent subtle widespread alterations 
to similar brain networks involved in motor control may be present. To further examine this, 
MRI studies on anatomical and functional brain networks would be useful. 
 
 
While the majority of children in our sample with HIE without CP scored in the normal range 
for sleep behaviour, the incidence of clinically relevant sleep problems was over twice that 
reported in typically developing children. Furthermore, in our study, significantly more sleep 
problems were reported in children with MNS compared to those with normal neurology. 
Other studies have also indicated problems with sleep behaviour in children with HIE. For 
example, Ding et al (2016) 32 reported that overall sleep times of 3-year-old children with 
HIE were shorter than those of typically developing, age-matched controls, potentially due to 
difficulties in sleep initiation and maintenance, as well as breathing problems during sleep. 
Additionally, there was an indication that different types of difficulties may be experienced 
by children with mild and moderate HIE. Sleep-related problems in children with HIE can be 
observed shortly after birth. Infants with HIE show a delay in development of the sleep-wake 
cycle measured using EEG 33,34, a delay which is related to the severity of HIE 33. 
Furthermore, long-term developmental outcome was related to the onset of the sleep-wake 
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cycle; 1 to 5.5 year-old-children with HIE whose newborn sleep-wake cycle started before 36 
hours had Griffiths scores 8.5 points higher than those whose newborn sleep-wake cycle 
started after 36 hours 33. These findings should be followed up in a systematic manner to 
evaluate both the presence and type of sleep problems, and the relation to long-term outcome. 
 
 
As TH is now standard treatment for moderate to severe HIE, contemporaneous comparisons 
of TH treated and non-treated children is no longer possible. Moving forwards, it may be of 
particular interest and relevance to compare children with HIE treated with TH with their age 
matched peers without HIE, in order to explore how they are performing later in life. With 
regards to assessment of neurology and neuromotor function, it will be important in future 
research to use specifically designed standardised and validated tools for detection of minor 




Our findings have implications for clinical practice. Children surviving HIE who do not 
present with CP are often routinely discharged from clinical care at age 2 years. Children 
surviving HIE who present with MNS are rarely followed up clinically beyond 2 years of age. 
Furthermore, clinicians who perform follow-up assessments are not always trained to detect 
MNS. Our findings suggest that children surviving HIE with MNS are at heightened risk of 
impairment in multiple domains compared to children with HIE who exhibit normal 
neurology. This suggests that these children may benefit from a longer period of routine 
clinical follow up to monitor their development and to provide appropriate support. 
 
 
Important limitations of our work include the relatively small sample size of the cohort and 
that not all children completed the follow-up assessment. As there were no significant 
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baseline differences between tested and not tested children, while possible, it seems unlikely 





In conclusion, in our clinical cohort of children with HIE without CP treated with TH, our 
two-year follow-up found that the majority of the sample showed typical development for 
cognition, motor skills, and language. There was no strong evidence of increased autistic 
traits, but more children exhibited externalising symptoms in the clinical range than in the 
general population. The subgroup of children with HIE and MNS consistently experienced 
greater difficulties across multiple domains than those with normal neurology, with 
difficulties in internalising behaviour, sleep, and other problems. Therefore, this group may 
benefit from enhanced clinical follow up to monitor their development, including sleep 
patterns, and to allow physicians to identify those who would benefit from early intervention. 
In addition, clinicians should be trained to identify minor neurological signs in these children 
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Figure 1: Study population. Children eligible for this study were admitted to Neonatal Unit 
for consideration of hypothermia treatment (TH) for neonatal HIE, University Hospital 





107 received 2-year 
follow up 






20 had neurological assessment 






















94/107 did not develop CP and are included in the final analyses 
of this study 
20 lost to follow-up 
127 surviving infants 
17 excluded since primary 
diagnosis other than perinatal 
asphyxia as cause for 
encephalopathy 
194 newborns admitted for 
TH for neonatal HIE 
following perinatal 
asphyxia 
140 newborns with primary 
diagnosis of perinatal 
asphyxia as cause for 
encephalopathy and 72 hours 
of TH 




Table 1: Demographic data for tested and untested surviving newborns with perinatal 
asphyxia and those treated with TH; note that this table excludes newborns who had other 
diagnoses than perinatal asphyxia as primary cause for encephalopathy and includes the 




























N=140 N=13 N=20 N=107 
 
Birth Weight (g), 3451.6 3951.0 3361.1 3375.2 0.5 
mean (SD) (680.5) (687.7) (708.7) (653.8)  
 min 1540- min 2950- min 1540- min 2200-  
 max 4980 max 4930 max 4625 max 4980  
Gestational age 39.7 (1.7) 39.7 (1.1) 39.5 (1.9) 39.7 (1.6) 0.36 
(wk), mean (SD) min 34- min 37- min 34- min 35 -max  
 max 42.1 max 41 max 42 42  
Sex, n 
male/female 
67/73 7/6 10/10 50/57 0.16 
Mode of delivery     0.10 
n (%)      
Spontaneous 56 (40) 2 (15.4) 5 (25) 49 (45.8)  
vaginal      
Forceps 12 (8.6) 1 (7.7) 1 (5) 10 (9.3)  
Ventouse 5 (3.6) - 2 (10) 3 (2.8)  
Planned 4 (2.2) - - 4 (3.7)  
Caesarean      
Emergency 63 (45) 10 (76.9) 12 (60) 41 (38.3)  
Caesarean      
^Apgar at 10 5.04 (2.3) 3.1 (2.8) 5.1 (2.5) 5.3 (2.1) 0.21 
minutes, mean min 0-max min 0-max min 1-max min 0-max  
(SD) 10 9 9 10  
^^Cord PH 6.9 (0.2) 6.9 (0.1) 6.7 (0.2) 6.9 (0.2) 0.51 
(arterial), mean min 6.5- min 6.6 - min 6.6- mx min 6.5 –  









- max -2.4 
-13.4 (9.9) 
min -30 – 
max -2 
-15.4 (7.3) 






Seizures, n (%) 
yes 
65 (46.4) 10 (76.9) 6 (30) 49 (45) 0.29 
^ Information missing for 1 newborn who died. ^^ Information missing for 11 newborns 
overall (for 2 newborns who died; for 3 newborns who were lost to FU; for 6 newborns who 
were seen at age 2 years). ^^^ Information missing for 11 newborns who were seen at age 2 
years). * Information missing for 4 newborns overall (for 3 newborns who died; for 1 
newborn who was lost to follow-up) 
Percentages given are percentages based on available data for each variable in each group. 
~ Comparison between the group who was lost to follow-up and the group for which were 
follow-up information available: Chi-Square and Fisher’s Exact test for categorical data, 
Mann-Whitney U test for continuous data. 
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Table 2: Results from testing with the Bayley-3 Scales for the 71 children who underwent 




 Neuromotor status n (%)  



























score, mean (SD), min- 
max 
106.1 (16.4) 
min 65-max 145 
107.1 (16.8) 





** Language composite 
score, mean (SD), min- 
max 
102.9 (15.7) 
min 59-max 141 
104.4 (15.2) 











min 4-max 17 
8.9 (2.1) 
min 5-max 12 
0.04 
**Language expressive 









*** Motor composite 
score, mean (SD), min- 
max 
105.0 (12.5) 
min 82-max 136 
106.0 (12.3) 





*** Fine motor scaled 






min 7-max 18 
0.84 
*** Gross motor scaled 






min 6- max 12 
0.003 
* Data available for 71 children; ** data available for 65 children; *** data available for 69 
children 
&Group comparison between normal neurology and minor neurological signs performed with: 
Mann Whitney U- Test 
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 Neuromotor status, n 
Normal 
n=8 





Normal 8/8 2/2 
Borderline 0 0 
Delayed 0 0 
ASQ Gross Motor Skills   
Normal 7/8 1/2 
Borderline 1/8 0 
Delayed 0 1/2 
ASQ Fine Motor Skills   
Normal 7/8 2/2 
Borderline 0 0 
Delayed 1/8 0 
ASQ Problem Solving   
Normal 7/8 2/2 
Borderline 1/8 0 




Normal 7/8 2/2 
Borderline 1/8 0 
Delayed 0 0 
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Table 4: Results from the CBCL 1.5-5 parental questionnaire for children who had TH and 
did not develop Cerebral Palsy, categorised by neuromotor status 
 
 Neuromotor status n (%)  






























^CBCL Total Problem 
Score 
33.4 (28.6) 
min 0-max 117 
29.1 (26.4) 
min 0-max 117 
56.7 (37.3) 
min 4-max 108 
0.04 
^CBCL Internalising 




min 0-max 31 
14.4 (11.9) 
min 0-max 34 
0.03 





min 0-max 8 
4.8 (4.9) 
min 0-max 15 
0.06 
^CBCL Internalising - 
Anxious/depressed 
2.1 (2.7) 
min 0-max 13 
1.8 (2.3) 
min 0-max 13 
4.4 (4.1) 
min 0-max 13 
0.04 
^CBCL Internalising - 
Somatic complaints 
1.8 (2.3) 
min 0-max 10 
1.5 (1.9) 
min 0-max 8 
3.5 (3.4) 
min 0-max 10 
0.07 
^CBCL Internalising - 
Withdrawn 
1.2 (2.1) 
min 0-max 12 
0.97 (1.5) 
min 0- max 7 
1.7 (2.7) 
min 0-max 8 
0.7 
^CBCL Externalising 
Score, mean (SD) 
13.1 (10.9) 
min 0-max 41 
12.0 (10.4) 
min 0-max 41 
20.3 (13.3) 
min 0-max 38 
0.09 
^CBCL Externalising - 
Attention 
2.8 (2.7) 
min 0-max 10 
2.5 (2.7) 
min 0 – max 9 
3.9 (3.2) 
min 0-max 10 
0.15 
^CBCL Externalising - 
Aggression 
10.1 (8.5) 
min 0-max 33 
9.4 (8.2) 
min 0 – max 33 
15.8 (10.1) 
min 0-max 28 
0.06 
^CBCL Sleep problems 3.01 (3.7) 
min 0-max 14 
2.6 (3.4) 
min 0-max 14 
5.9 (5.0) 
min 0-max 14 
0.04 
^CBCL Other problems 10.1 (8.9) 
min 0-max 36 
8.6 (8.5) 
min 0-max 36 
17.0 (9.9) 
min 3-max 31 
0.01 
CBCL, Child Behavior Checklist, raw scores used; data available for 74 children 
&Group comparison between normal neurology and minor neurological signs performed with 
Mann Whitney U- Test 
